Hodgkins Disease, An Issue of Hematology/Oncology Clinics,21-5, V. Diehl
Нет в продаже. Поставка невозможна
Автор: Longo Название: Harrison`S Hematology/Oncology ISBN: 0071663355 ISBN-13(EAN): 9780071663359 Издательство: McGraw-Hill Рейтинг: Цена: 4492 р. Наличие на складе: Поставка под заказ.
The authority of "Harrison's" in a handy, full-color paperback devoted exclusively to Hematology and Oncology
A Doody's Core Title for 2011
Featuring the chapters on Hematology and Oncology that appear in the landmark "Harrison's Principles of Internal Medicine, 17e," this compact clinical companion delivers all the latest knowledge in the field, backed by the scientific rigor and reliability that have defined "Harrison's."
You'll find coverage that reflects the expertise of renowned editors and contributors -- presented in a carry-anywhere format that makes it ideal for the classroom, the wards, or the point of care. With its ease of use, indispensable diagnosis-speeding guidelines, and acclaimed state-of-the-art strategies, "Harrison's Hematology and Oncology" is a must for students and clinicians alike.
"Harrison's Hematology and Oncology" delivers: A unique single-source reference featuring hard-to-find integrated information on hematology and oncology Integration of pathophysiology with clinical management topics in each of the disease-oriented chapters Valuable content in print form from the acclaimed "Harrison's 17e" DVD 52 chapters written by physicians who have made seminal contributions in their areas of expertise 115 high-yield self-assessment Q&A for exam and board review, drawn from "Harrison's Principles of Internal Medicine Self-Assessment and Board Review, 17e" Complete coverage of need-to-know hematology and oncology topics, including the latest information on hematopoiesis, cancer cell biology, and cancer prevention Helpful appendix that highlights laboratory values of clinical importance
Everything you would expect from "Harrison's" tailored to your specialty Condensed Table of Contents: The Cellular Basis of Hematopoiesis; Cardinal Manifestations of Hematologic Disease; Anemias; Myeloproliferative Disorders; Hematologic Malignancies; Disorders of Hemostasis; Biology of Cancer; Principles of Cancer Prevention and Treatment; Neoplastic Disorders; Endocrine Neoplasia; Remote Effects of Cancer; Oncologic Emergencies and Late Complications.
The "Harrison's" specialty series is written by the same world-renowned author team who brought you "Harrison's Principles of Internal Medicine, 17e" Anthony S. Fauci, MD; Eugene Braunwald, MD; Dennis L. Kasper, MD; Stephen L. Hauser, MD; Dan L. Longo, MD; J. Larry Jameson, MD, PhD; Joseph Loscalzo, MD, PhD
Автор: Rodgers Название: The Bethesda Handbook of Clinical Hematology ISBN: 1451182708 ISBN-13(EAN): 9781451182705 Издательство: Lippincott Williams & Wilkins Рейтинг: Цена: 4912 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: Packed with essential information on the diagnosis and treatment of blood and bone marrow disorders, The Bethesda Handbook of Clinical Hematology, Third Edition should be carried in the white coat pocket of the student, resident, or hematology/oncology service and in the briefcase of the internist, hospitalist, family practitioner, and pediatrician who sees patients with blood diseases. Look inside and discover…• Organization by disease category makes critical information easy to find and use.• Reader-friendly format includes tables, algorithms, meaningful figures, and bulleted lists that highlight vital facts.• Invaluable contributions from recognized experts and senior fellows bridge the gap between science and the clinical practice.• Concise coverage of the diagnosis and treatment makes the handbook ideal for quick reference, as well as for Board review! NEW to the Third Edition…• Emerging diagnostic and treatment strategies refine clinical decision-making.• Significantly revised and updated chapters describe recent advances in diagnosis and treatment of hematologic disorders. Put this handy and portable guide to work for you and your patients…Pick up your copy today!
Автор: Turgeon Mary Название: Clinical Hematology ISBN: 1608310760 ISBN-13(EAN): 9781608310760 Издательство: Lippincott Williams & Wilkins Рейтинг: Цена: 8465 р. Наличие на складе: Поставка под заказ.
Описание: Now in its Fifth Edition, Clinical Hematology covers the theory and procedures involved in the medical diagnosis and treatment of various disorders of the blood and bone marrow. Presented in a highly readable and engaging format, this text is ideally suit
Автор: Lichtman Название: Williams Manual Of Hematology ISBN: 007162242X ISBN-13(EAN): 9780071622424 Издательство: McGraw-Hill Рейтинг: Цена: 6269 р. Наличие на складе: Невозможна поставка.
Описание: A compilation of the pathogenic, diagnostic, and therapeutic essentials of blood cell and coagulation protein disorders. Covering both common and uncommon blood disorders, it includes sections on: Disorders of red cells; Disorders of granulocytes; Disorders of monocytes and macrophages; The clonal myeloid disorders; and, more.
Описание: This issue focuses on platelet disorders that are routinely encountered by practicing hematologists. Since there is a rapidly expanding body of information
currently available in this discipline, we have assembled a wide variety of topics by experts in their respective fields. For example, the chapter on assessment of platelet function covers
standard assay methods as well as more advanced testing and point of care tests.
Similarly, recent advances in the management of heparin induced thrombocytopenia (HIT),
thrombotic thrombocytopenic purpura (TTP) and immune thrombocytopenia (ITP) are discussed by authors who have performed original research in these areas. Other interesting topics
include anti-platelet drug therapy, drug-induced thrombocytopenia and current evidence-based platelet transfusion therapy.Apart from congenital and acquired platelet dysfunction, a
chapter on hyperactive platelets is included because evidence is emerging that supports the hypothesis that increased platelet function can cause thrombotic disorder. It is our sincere
hope that this compendium of articles will ease the burden of the practicing hematologist and simplify the task of treating patients with platelet disorders
Описание: Hairy cell leukemia (HCL) has assumed a level of great medical importance, despite its relative rarity as a chronic lymphoid leukemia. This is because it is a
unique, and peculiar, clinicopathologic entity which demonstrates unparalleled sensitivity to systemic therapy. Accordingly, it has served as a model for rational drug
Although splenectomy regularly normalizes the disease-associated cytopenias, it is now principally of historic interest because there are three agents approved
to treat HCL, namely, interferon, pentostatin and cladribine. We found that single infusions of cladribine, administered continuously over seven days, induce response rates greater than
95 per cent, 85 per cent of which are complete and durable. More recently, the monoclonal antibody, rituximab, and the recombinant immunotoxin, BL22, have found application in the
treatment of this disease.
Given the effectiveness of systemic treatments in HCL, it is absolutely mandatory that this entity be recognized when present. In this issue of
Hematology/Oncology Clinics of North America expert hematopathologists and clinicians, carefully selected, review the very latest pathologic, clinical and therapeutic advances in this
disease, and deliberate how this information can be translated into a curative strategy.
Описание: The full spectrum of central nervous system lymphoma is covered from patheology and genetics to clinical features, diagnosis and treatment. Also explored are
new approaches to therapy and unusual variants of central nervous system lymphoma.
Описание: This issue contains a comprehensive review of the most relevant information about targeted therapies, including preclinical studies as well as clinical trials that
are ongoing. Attention is given to the main Tirosine Kinase inhibitors, such as anti-EGFR and multitargeted therapies. The newly developed therapies against intracellular pathways
responsible for the tumor phenotype (mTOR inhibitors, farnesyltransferase inhibitors, and heat sock protein inhibitors) are also presented.
This information is important because
these new drugs are being tested in the clinical setting